XML 84 R72.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Combinations (Pro Forma Information) (Details) - NPS Pharma - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Pro Forma Information    
Revenues $ 6,446.6 $ 6,246.1
Net income from continuing operations $ 1,293.6 $ 2,950.7
Net income from continuing operations per share - basic $ 2.191 $ 5.029
Net income from continuing operations per share - diluted $ 2.181 $ 4.990
Pro Forma Data Adjustments    
An adjustment to increase amortization of intangible assets $ (22.2) $ (177.0)
Increase/(decrease) to net income to reflect acquisition related costs 105.3 (105.3)
Decrease to net income to reflect the additional interest expense   (22.2)
Increase/(decrease) to net income to reflect the fair value adjustment to acquisition date inventory. $ 18.8 $ (18.8)